What is Alto Neuroscience's loss on debt extinguishment?

Alto Neuroscience (ANRO) reported loss on debt extinguishment of $0 in Q1 2026.

How has Alto Neuroscience's loss on debt extinguishment changed year-over-year?

Alto Neuroscience's loss on debt extinguishment increased by 100.0% year-over-year, from -$681K to $0.

Non-cash loss from retiring debt before maturity, added back in operating cash flow since the cash impact is in financing.

RevvityRVTY

$0—

Operating income-$27.1M-73.1%

Net income-$26.2M-73.0%

EPS (diluted)-$0.80-42.9%

Cash & equivalents$264.3M+63.9%

Total debt$20.9M-17.2%

Total equity$243.4M+75.0%

Total assets$276.3M+60.7%

Operating cash flow-$27.1M-63.6%

CapEx$556.0K+2,217%

Free cash flow-$27.6M-66.7%

Market cap$887.88M+1,358%

Enterprise value$644.49M-958%

Return on equity-38.9%+0.9pp

Debt / equity0.1×-0.1×

Current ratio20.5×-2.0×

Reported directly by Alto Neuroscience in its filing.

Tagged under the XBRL concept us-gaap:GainsLossesOnExtinguishmentOfDebt.

The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and see it in context, right in your chat.

What is Alto Neuroscience's loss on debt extinguishment?: Alto Neuroscience (ANRO) reported loss on debt extinguishment of $0 in Q1 2026.
How has Alto Neuroscience's loss on debt extinguishment changed year-over-year?: Alto Neuroscience's loss on debt extinguishment increased by 100.0% year-over-year, from -$681K to $0.
What does loss on debt extinguishment mean?: Non-cash loss from retiring debt before maturity, added back in operating cash flow since the cash impact is in financing.